Lung Transplant

Bronchoscopic lung volume reduction (BLVR) is a minimally invasive option, performed using a valve to block diseased parts of the lung and allow healthier areas to inflate and work better.

Probe-based confocal laser endomicroscopy can be used in follow-up to directly view the lungs at a microscopic level after lung transplantation. This allows surgeons to monitor for acute cellular rejection after transplantation. We are partnering with France to secure the latest technology for our patients.

Our highly skilled physicians have expertise in the use of extracorporeal membrane oxygenation (ECMO), which uses a pump to circulate blood through an artificial lung to oxygenate the blood, providing a bridge for patients who might not otherwise survive long enough to receive a lung transplantation.

Lung volume reduction surgery (LVRS) is a surgical procedure that removes damaged lung tissue in patients with severe emphysema in order to improve the function of the remaining lung tissue.

Lung transplantation is a surgical procedure in which a patient’s diseased lungs are partially or totally replaced by lungs from an organ donor.

This innovative technique allows us to serve patients whose personal beliefs prohibit the use of blood transfusion.

Montefiore Einstein performed the first life-saving, combined lung-liver transplant in New York State. Our surgeons perform dual organ transplants (heart-lung, lung-kidney, lung-liver), all of which are considered rare.

This condition occurs when the heart can’t pump or fill with enough blood, forcing it to work harder to deliver blood to the body. Advanced heart disease can also be called congestive heart failure, pulmonary edema, fluid in the lungs or ventricular dysfunction.

COPD is a lung disease that makes it difficult to breathe. It is caused by damage to the lungs over many years caused by smoking or environmental factors.

Caused by scarring and blood clots, chronic thromboembolic pulmonary hypertension (CTEPH) occurs when there is high blood pressure in the small blood vessels of the lungs. CTEPH is treatable. However, if left untreated, patients with CTEPH have a reduced life expectancy.

Cystic fibrosis is a progressive, genetic disease that affects the lungs, pancreas and other organs. In the lungs, mucus clogs the airways and can lead to infections, inflammation, respiratory failure and other complications.

Emphysema is a lung disease that causes shortness of breath due to damage of the air sacs (alveoli). Emphysema can be caused by smoking, vaping, air pollution, or exposure to chemical fumes. Additional symptoms include coughing and fatigue.

Caused by environmental exposure, genetics or lifestyle habits, interstitial lung disease (ILD) refers to a group of diseases that cause scarring (fibrosis) of the lungs. The scarring makes it difficult to breathe and get sufficient oxygen to the bloodstream. Lung damage from ILD is often irreversible and gets worse over time.

Pulmonary hypertension occurs when pressure in the blood vessels leading from the heart to the lungs is too high. This condition affects the arteries in the lungs and the right side of the heart.